CHF5074, a novel γ‐secretase modulator, attenuates brain β‐amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
Open Access
- 31 March 2009
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 156 (6) , 982-993
Abstract
Background and purpose: We evaluated the effects of 1‐(3′,4′‐dichloro‐2‐fluoro[1,1′‐biphenyl]‐4‐yl)‐cyclopropanecarboxylic acid (CHF5074), a new γ‐secretase modulator, on brain β‐amyloid pathology and spatial memory in transgenic mice expressing the Swedish and London mutations of human amyloid precursor protein (hAPP).Experimental approach: Sixty 6‐month‐old hAPP mice were treated for 6 months with CHF5074 or ibuprofen (375 ppm in the diet) or standard diet. Twenty‐one wild‐type mice received standard diet.Key results: Compared with transgenic controls, CHF5074 treatment significantly reduced the area occupied by plaques in cortex (P = 0.003) and hippocampus (P = 0.004). The number of plaques were also reduced by CHF5074 in both cortex (P = 0.022) and hippocampus (P = 0.005). Plaque‐associated microglia in CHF5074‐treated animals was lower than in transgenic controls in cortex (P = 0.008) and hippocampus (P = 0.002). Ibuprofen treatment significantly reduced microglia area in cortex and hippocampus but not β‐amyloid burden. On the last day of the Morris water maze, transgenic controls performed significantly worse than the non‐transgenic animals and the CHF5074‐treated transgenic mice, on the swimming path to reach the hidden platform. Ibuprofen‐treated animals did not perform significantly better than transgenic controls.Conclusions and implications: Chronic CHF5074 treatment reduced brain β‐amyloid burden, associated microglia inflammation and attenuated spatial memory deficit in hAPP mice. This novel γ‐secretase modulator is a promising therapeutic agent for Alzheimer's disease.Keywords
This publication has 39 references indexed in Scilit:
- Amyloid‐β oligomers set fire to inflammasomes and induce Alzheimer's pathologyJournal of Cellular and Molecular Medicine, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Substrate-targeting γ-secretase modulatorsNature, 2008
- Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticityBrain, 2008
- Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein miceBMC Neuroscience, 2007
- In vitro and in vivo profiling of CHF5022 and CHF5074Pharmacological Research, 2007
- Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2005
- Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of β-Amyloid1-42SecretionJournal of Medicinal Chemistry, 2005
- Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's ModelsNeuropsychopharmacology, 2005
- Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP CleavagesBiochemistry, 2003